Dissociating medication effects from learning and practice effects in a neurocognitive study of schizophrenia: Olanzapine versus haloperidol

Cognitive Neuropsychiatry

Volumn 12, Issue 4, 2007, Pages 322-338

  Boulay, Luc J ^a,c   Labelle, Alain ^a   Bourget, Dominique ^a   Robertson, Sharman ^a   Habib, Rami ^a   Tessier, Pierre ^a   Tombaugh, Tom ^b   Milin, Robert ^a  

^a ROYAL OTTAWA HOSPITAL   (Canada)

^b CARLETON UNIVERSITY   (Canada)

^c Carleton University ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; OLANZAPINE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; ATTENTION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; LEARNING; MALE; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SHORT TERM MEMORY; WORKING MEMORY;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HUMANS; MALE; MENTAL PROCESSES; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA;

EID: 34250161755     PISSN: 13546805     EISSN: 14640619     Source Type: Journal    
DOI: 10.1080/13546800601069534     Document Type: Article

References (48)

1. Addington, D., Addington, J., & Schissel, B. (1990). A depression rating scale for schizophrenics. Schizophrenia Research, 3, 247-251.
2. Beasley, C. M. J., Tollefson, G., Tran, P., Satterlee, W., Sanger, T., & Hamilton, S. (1996). Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology, 14, 111-123.
3. Beglinger, L. J., Crawford-Miller, J., & Kareken, D. A. (2003). Neuropsychological practice effects and change detection in people with schizophrenia. Schizophrenia Research, 62, 191-194.
4. Bédard, M. A., Scherer, H., Delorimier, J., Stip, E., & Lalonde, P. (1996). Differential effects of D2-and D4-blocking neuroleptics on the procedural learning of schizophrenic patients. Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie, 41, S21-S24.
5. Bédard, M. A., Scherer, H., Stip, E., Cohen, H., Rodriguez, J. P., & Richer, F. (2000). Procedural learning in schizophrenia: Further consideration on the deleterious effect of neuroleptics. Brain and Cognition, 43, 31-39.
6. Bilder, R. M., Goldman, R. S., Volavka, J., Czobor, P., Hoptman, M., Sheitman, B., et al. (2002). Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. American Journal of Psychiatry, 159, 1018-1028.
7. Blyler, C. R., & Gold, J. M. (2000). Cognitive effects of typical antipsychotic treatment: Another look. In T. Sharma & P. D. Harvey (Eds.), Cognitive deficits in schizophrenia (pp. 241-265). Oxford, UK: Oxford University Press.
8. Brickenkamp, R., & Zillmer, E. (1998). The d2 test of attention. Seattle, WA: Hogrefe & Huber Publishers.
9. Cassens, G., Inglis, A. K., Appelbaum, P. S., & Gutheil, T. G. (1990). Neuroleptics: Effects on neuropsychological function in chronic schizophrenic patients. Schizophrenia Bulletin, 16, 477-499.
10. Dikmen, S. S., Heaton, R. K., Grant, I., & Temkin, N. R. (1999). Test-retest reliability and practice effects of Expanded Halsted-Reitan Neuropsychological Test Battery. Journal of the International Neuropsychological Society, 5, 346-356.
11. Golden, C. J. (1978). Stroop Color and Word Test: Manual for clinical and experimental uses. Chicago: Stoelting Company.
12. Green, M. F. (1998). Schizophrenia from a neurocognitive perspective: Probing the impenetrable darkness. Boston: Allyn & Bacon.
13. Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000). Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the "right stuff"? Schizophrenia Bulletin, 26 (1), 119-136.
14. Green, M. F., Marder, S. R., Glynn, S. M., McGurk, S. R., Wirshing, W. C., Wirshing, D. A., et al. (2002). The neurocognitive effects of low-dose haloperidol: A two-year comparison with risperidone. Biological Psychiatry, 51, 972-978.
15. Gregory, R. J. (1987). Adult intellectual assessment. Boston: Allyn & Bacon.
16. Harvey, P. D., & Keefe, R. S. (2001). Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. American Journal of Psychiatry, 158, 176-184.
17. Harvey, P. D., Moriarty, P. J., Serper, M. R., Schnur, E., & Lieber, D. (2000). Practice-related improvement in information processing with novel antipsychotic treatment. Schizophrenia Research, 46, 139-148.
18. Hill, S. K., Schuepbach, D., Herbener, E. S., Keshavan, M. S., & Sweeney, J. A. (2004). Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naive patients with schizophrenia. Schizophrenia Research, 68, 49-63.
19. Kapur, S., Remington, G., Jones, C., Wilson, A., DaSilva, J., Houle, S., et al. (1996). High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: A PET study. American Journal of Psychiatry, 153, 948-950.
20. Kay, S. R., Opler, L. A., & Fiszbein, A. (1986). Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-276..
21. Keefe, R. S., Seidman, L. J., Christensen, B. K., Hamer, R.M., Sharma, T., Sitskoorn, M. M., et al. (2004). Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: A randomized, double-blind trial of olanzapine versus low doses of haloperidol. American Journal of Psychiatry, 161, 985-995.
22. Kumari, V., Corr, P. J., Mulligan, O. F., Cotter, P. A., Checkley, S. A., & Gray, J. A. (1997). Effects of acute administration of d-amphetamine and haloperidol on procedural learning in man. Psychopharmacology (Berlin), 129, 271-276.
23. Kumari, V., Gray, J. A., Honey, G. D., Soni, W., Bullmore, E. T., Williams, S. C., et al. (2002). Procedural learning in schizophrenia: A functional magnetic resonance imaging investigation. Schizophrenia Research, 57, 97-107.
24. Lezak, M. (1995). Neuropsychological assessment (3rd ed.). New York: Oxford University Press.
25. Marder, S. R., & Fenton, W. (2004). Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophrenia Research, 72, 5-9.
26. McCaffrey, R. J., Duff, K., & Westervelt, H. J. (2002). Practitioner's guide to evaluating change with neuropsychological assessment instruments. New York: Kluwer Academic/Plenum.
27. Mega, M. S., & Cummings, J. L. (1994). Frontal-subcortical circuits and neuropsychiatric disorders. Journal of Neuropsychiatry and Clinical Neurosciences, 6, 358-370.
28. Meltzer, H. Y., & McGurk, S. R. (1999). The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophrenia Bulletin, 25, 233-255.
29. Nordstrom, A. L., Farde, L., Wiesel, F. A., Forslund, K., Pauli, S., Halldin, C., et al. (1993). Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients. Biological Psychiatry, 33, 227-235.
30. Oltmanns, T. F. (1978). Selective attention in schizophrenic and manic psychoses: The effect of distraction in information processing. Journal of Abnormal Psychology, 87, 212-225.
31. Oltmanns, T. F., & Neale, J. M. (1975). Schizophrenic performance when distractors are present: Attentional deficit or differential task difficulty. Journal of Abnormal Psychology, 84, 205-209.
32. Palermero-Neto, J. (1997). Dopaminergic systems: Dopamine receptors. Psychiatric Clinics of North America, 20, 705-721.
33. Paquet, F., Soucy, J. P., Stip, E., Levesque, M., Elie, A., & Bedard, M. A. (2004). Comparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D2 receptor occupancy in schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences, 16, 47-56.
34. Peretti, C. S., Danion, J. M., Kauffmann-Muller, F., Grange, D., Patat, A., & Rosenzweig, P. (1997). Effects of haloperidol and amisulpride on motor and cognitive skill learning in healthy volunteers. Psychopharmacology (Berlin), 131, 329-338.
35. Purdon, S. E., Jones, B. D., Stip, E., Labelle, A., Addington, D., David, S. R., et al. (2000). Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. Archives of General Psychiatry, 57, 249-258.
36. Purdon, S. E., Malla, A., Labelle, A., & Lit, W. (2001). Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. Journal of Psychiatry and Neuroscience, 26, 137-149.
37. Purdon, S. E., Woodward, N., Lindborg, S. R., & Stip, E. (2003). Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol. Psychopharmacology (Berlin), 169, 390-397.
38. Sax, K. W., Strakowski, S. M., & Keck, P. E., Jr. (1998). Attentional improvement following quetiapine fumarate treatment in schizophrenia. Schizophrenia Research, 33, 151-155.
39. Scherer, H., Stip, E., Paquet, F., & Be dard, M. A. (2003). Mild procedural learning disturbances in neuroleptic-naive patients with schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 58-63.
40. Serper, M. R., Bergman, R. L., & Harvey, P. D. (1990). Medication may be required for the development of automatic information processing in schizophrenia. Psychiatry Research, 32, 281-288.
41. Smith, R. C. I. (2001). The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia. International Journal of Neuropsychopharmacology, 4, 239-250.
42. Spohn, H. E., & Strauss, M. E. (1989). Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. Journal of Abnormal Psychology, 98, 367-380.
43. Takano, K., Ito, M., Kobayashi, K., Sonobe, N., Kurosu, S., Mori, Y., et al. (2002). Procedural memory in schizophrenia assessed using a mirror reading task. Psychiatry Research, 109, 303-307.
44. Tombaugh, T., & Francis, M. (1999a). Same-different experiment [Computer software]. Unpublished test, Carleton University, Ottawa, Ontario, Canada.
45. Tombaugh, T., & Francis, M. (1999b). Simple reaction time [Computer software]. Unpublished test, Carleton University, Ottawa, Ontario, Canada.
46. Wechsler, D. (1987). Wechsler Memory Scale - Revised manual. San Antonio, TX: Psychological Corporation.
47. Wechsler, D. (1997). WAIS-III administration and scoring manual (3rd ed.). San Antonio, TX: Harcourt Brace & Co.
48. Woodward, N. D., Purdon, S. E., Meltzer, H. Y., & Zald, D. H. (2005). A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. International Journal of Neuropsychopharmacology, 8, 457-472.